With shares of Corning (NYSE:GLW) trading around $15, is GLW an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s Movement
Corning produces and sells specialty glasses, ceramics, and related materials worldwide. It operates through five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences.�Corning launched Corning Lotus Glass, an environmentally friendly display glass for organic LED and LCD displays that are used in portable devices, such as smart phones, tablets, and notebook computers. Smart phones, tablets, and notebook computers and their related materials are seeing explosive growth in developed and developing countries around the world. Companies that provide the products necessary to develop and improve existing technology, like Corning, will see a continued rise in profits as consumers and companies demand products that maximize their efforts.
Top Low Price Companies To Watch In Right Now: Legal & General Group PLC (LGEN)
Legal & General Group Plc is a provider of risk, savings and investment management products in the United Kingdom. The Company's operating segments include Protection and Annuities segment consisting of individual and group protection, individual and bulk purchase annuities, longevity and general insurance; Savings segment consisting of non-profit investment bonds, non-profit pensions (including self-invested personal pensions (SIPPs)), individual savings account (ISAs), retail unit trusts and retail platform businesses; Investment management segment consisting of institutional fund management and LGIM America (LGIMA); US Protection segment consisting of individual protection and universal life contracts, and Group capital and financing consists of shareholders��equity supporting the non profit Protection and Annuities and Savings businesses. In August 2013, Legal & General Group Plc announced the acquisition of Lucida Limited. Advisors' Opinion:- [By Rupert Hargreaves]
Unfortunately, Prudential only offers a dividend yield of 2.4% at present, below that of its peers, such as Aviva (AV) and Legal & General (LGEN). Moreover, city analysts only expect Prudential to increase its payout by 10% this year and 5% during 2014.
10 Best Life Sciences Stocks To Own For 2014: Volkswagen AG (VLKAY)
Volkswagen AG is a Germany-based automobile manufacturer. The Company develops vehicles and components, and also produces and sells vehicles, in particular Volkswagen brand passenger cars and commercial vehicles. The Company consists of two divisions: Automotive and Financial Services division. The Automotive division is responsible for the development of vehicles and engines, the production and sale of passenger cars, commercial vehicles, trucks and buses, and the genuine parts business. The Financial services division's portfolio of services includes dealer and customer services in the field of financing, leasing, directbank, insurance and fleet business. The Company's brands include Volkswagen, Audi, Bentley, Bugatti, Lamborghini, SEAT, Skoda, Scania and Volkswagen Commercial Vehicles and each brand offers a product range from low-consumption small cars to luxury class vehicles, as well as pick ups, busses and heavy trucks in the commercial vehicle sector.
During 2009, the Company introduced two additions to the Audi5 model series: Audi A5 Cabriolet and the Audi A5 Sportback. In addition, Audi A4 allroad Quattro, Audi TT RS, Audi RS Spyder and the Audi 8 were introduced. During 2009, Audi brand delivered 950 thousand vehicles to customers worldwide. The SEAT launched the Exeo in the B segment. This sporty midsized saloon marks the arrival of the Spanish brands. Bentley introduced the Bentley Mulsanne. This saloon includes proportioned interiors. It also introduced GTC Speed and the Bentley Continental Supersports.
The Company has various delivery centers, including Western Europe, China, Brazil, United States and Mexico. During 2009, deliveries of vehicles were 6336222 worldwide.
Advisors' Opinion:- [By Dan Carroll]
One German auto firm that is poised to succeed, however, is Volkswagen (NASDAQOTH: VLKAY ) . VW has thrived in China, becoming one of the nation's market leaders and growing its sales rapidly. While a Chinese slowdown could cut back on VW's sales, the firm's sizable market share -- it had a 20% market share in China earlier in the year -- will help VW see through any slowdown in the overall market while holding on to its spot in the industry. If investors are looking for one manufacturing stock in Germany that won't be slowed down, this is it.
- [By John Rosevear]
Luxury cars are huge in China, where Volkswagen's (NASDAQOTH: VLKAY ) Audi brand rules the market, a market that is expected to grow rapidly for years to come. A bunch of big global automakers, including both General Motors (NYSE: GM ) and Ford (NYSE: F ) , are angling for a share of this rich pie -- and now, Honda (NYSE: HMC ) is throwing its hat into the ring.
10 Best Life Sciences Stocks To Own For 2014: Umpqua Holdings Corp (UMPQ)
Umpqua Holdings Corporation (Umpqua) is a financial holding company. Umpqua has two principal operating subsidiaries, Umpqua Bank (the Bank) and Umpqua Investments, Inc. (Umpqua Investments). The Bank is primarily engaged in the business of commercial and retail banking and the delivery of retail brokerage services. The Bank provides a range of banking, wealth management, mortgage banking and other financial services to corporate, institutional and individual customers. Umpqua Investments is a broker-dealer and investment advisor with offices in Portland, Lake Oswego, Medford, Oregon, and in many Umpqua Bank stores. Umpqua Investments offers a range of investment products and services, including stocks, fixed income securities (municipal, corporate, and government bonds, Certificate of Deposits (CDs), and money market instruments), mutual funds, annuities, options, retirement planning, money management services and life insurance. In December 2011, the Bank launched a commercial real estate division. In November 2012, the Company acquired Circle Bancorp, parent company of Circle Bank. In July 2013, Umpqua Holdings Corp completed its acquisition of Financial Pacific Holding Corp.
The Company offers a Switch Kit, which allows a customer to open a primary checking account with Umpqua Bank in less than 10 minutes. Other avenues, through which customers can access its products, include its Website equipped with an e-switchkit, which includes Internet banking through umpqua.online, mobile banking, and its 24-hour telephone voice response system. Umpqua Private Bank serves high net worth individuals with liquid investable assets by providing customized financial solutions and offerings. Umpqua private bank works collaboratively with the Bank�� affiliate retail brokerage Umpqua Investments and with the independent capital management firm Ferguson Wellman Capital Management. Umpqua Investments provides a range of brokerage services, including equity and fixed income products, mutual funds, annui! ties, options, retirement planning and money management services. Additionally, Umpqua Investments offers life insurance policies. At December 31, 2011, Umpqua Investments had 41Series seven-licensed financial advisors serving clients at three stand-alone retail brokerage offices and Investment Opportunity Centers located in many Bank stores.
Lending Activities
Umpqua offers loans for business and commercial customers, including accounts receivable and inventory financing, equipment loans, international trade, real estate construction loans and permanent financing and SBA program financing, as well as capital markets and treasury management. Additionally, it offers designed loan products for small businesses through its Small Business Lending Center. It also has a business banking division to increase lending to small and mid-sized businesses. The Company is also engaged in initiatives that continue to diversify the loan portfolio, including a focus on commercial and industrial loans in addition to financing owner-occupied properties.
Real estate loans are available for construction, purchase and refinancing of residential owner-occupied and rental properties. Borrowers can choose from a variety of fixed and adjustable rate options and terms. It sells residential real estate loans that originate into the secondary market. It also supports the Home Affordable Refinance Program and Home Affordable Modification Program. The Bank also provide loans to individual borrowers for a variety of purposes, including secured and unsecured personal loans, home equity and personal lines of credit and motor vehicle loans. The Bank makes both secured and unsecured loans to individuals and businesses. During 2011, its commercial real estate, commercial, residential, and consumer and other represented approximately 64%, 25%, 10%, and 1%, respectively, of the total non-covered loan and lease portfolio.
Source of Funds
The Company offers an array of deposit p! roducts, ! including non-interest-bearing checking accounts, interest-bearing checking and savings accounts, money market accounts and certificates of deposit. These accounts earn interest at rates established by management based on market factors. It also offers a seniors program to customers over fifty years old, which includes an array of banking services and other amenities, such as purchase discounts, vacation trips and seminars.
Investment Activities
As of December 31, 2011, Umpqua's portfolio of investments securities included securities issued by United States Treasury and agencies, and residential mortgage-backed securities and collateralized mortgage obligations. It also includes obligations of states and political subdivisions, other debt securities, and investments in mutual funds and other equity securities.
Advisors' Opinion:- [By Roberto Pedone]
Umpqua (UMPQ) is engaged in the business of commercial and retail banking and the delivery of retail brokerage services. This stock closed up 5% at $17.11 in Monday's trading session.
Monday's Volume: 2.16 million
Three-Month Average Volume: 686,781
Volume % Change: 235%From a technical perspective, UMPQ ripped sharply higher here right off its 50-day moving average of $16.51 with strong upside volume. This move is quickly pushing shares of UMPQ within range of triggering a big breakout trade. That trade will hit if UMPQ manages to take out Monday's intraday high of $17.46 and then once it clears its 52-week high at $17.48 with high volume.
Traders should now look for long-biased trades in UMPQ as long as it's trending above its 50-day at $16.51 or above more near-term support at $16 and then once it sustains a move or close above those breakout levels with volume that's near or above 686,781 shares. If that breakout hits soon, then UMPQ will set up to enter new 52-week-high territory above, which is bullish technical price action. Some possible upside targets off that breakout are $20 to $23.
10 Best Life Sciences Stocks To Own For 2014: Fusion Pharm Inc (FSPM)
Fusion Pharm, Inc., incorporated on January 21, 1998, manufactures and sells a patent pending commercial hydroponic cultivation system capable of growing almost any herb, vegetable, flower, fruit or terrestrial plant better and faster than traditional farming methods. The Company is the creator and manufacturer of the PharmPods hydroponic cultivation container system. The Company sells and licenses its PharmPods containers to agricultural equipment distributers, urban farming companies and other specialty growers. The Company is focused on the development and commercialization of its patent pending PharmPods cultivation container system. In February 2013, the Company completed the sale of 8 PharmPod High Intensity containers under its licensing agreement with Meadpoint Venture Partners (Meadpoint).
The Company's PharmPods are constructed of standard ISO steel shipping containers that are repurposed for use in hydroponic plant cultivation and are equipped with specialty lighting, irrigation systems, climate-control systems and ventilation for a grow-ready, self-contained agricultural solution. PharmPods allow users to precisely control what a plant receives, grow crops densely, avoid using pesticides, increase yields and automatically water plants.
The Company�� PharmPods are used for agricultural cultivation by urban faming companies and other specialty growers The Company does not own any real estate or other physical properties material to its operations. It operates from leased space.
Advisors' Opinion:- [By Dan Burrows]
From questions regarding the accuracy of publicly-available information about these companies��operations to potential illegal activity, these marijuana stocks have incurred the wrath of federal regulators for good reason:
GrowLife (PHOT) FusionPharm (FSPM) CannaBusiness Group (CBGI) Advanced Cannabis Solutions (CANN) Petrotech Oil and Gas (PTOG) Marijuana Stocks Asking for TroubleBut it doesn’t end there. Investors should run away from all OTC marijuana stocks, including Medical Marijuana (MJNA), Cannabis Science (CBIS), CannaVest (CANV), MediSwipe (MWIP) and GreenGro Technologies (GRNH). As the SEC warns:
10 Best Life Sciences Stocks To Own For 2014: Bovis Homes Group PLC (BVS)
Bovis Homes Group PLC is a builder of traditional homes in England and Wales. The Company�� business involves the designing, building and selling of new homes for both private and public sector customers. The Company delivers projects such as Land acquisition, Planning, Legal, Design, Surveying, Engineering, Purchasing, Construction, Sales and marketing, Public relations and Customer service. Advisors' Opinion:- [By Inyoung Hwang]
Bovis Homes Group Plc (BVS) climbed 4 percent to 790 pence. Liberum Capital Ltd. raised its rating on the housebuilder to buy from hold. Persimmon Plc (PSN), the U.K.�� largest residential property developer, gained 2.5 percent to 1,255 pence.
10 Best Life Sciences Stocks To Own For 2014: OncoSec Medical Inc (ONCS)
OncoSec Medical Incorporated, incorporated on February 8, 2008, is an emerging drug-medical device company. The Company focused on designing, developing and commercializing medical approaches for the treatment of solid cancers. In March 2011, the Company acquired from Inovio Pharmaceuticals, Inc. (Inovio) certain assets related to the use of drug-medical device combination products for the treatment of different cancers.
The Company�� acquired assets relate to certain non-deoxyribonucleic acid (DNA) vaccine technology and property relating to selective tumor ablation technologies, which it refers to as the OncoSec Medical System (OMS), a therapy which uses an electroporation device to facilitate delivery of chemotherapy agents, or nucleic acids encoding cytokines, into tumors and/or surrounding tissue for the treatment and diagnosis of various cancers. As of January 24, 2012, the Company had not generated any revenue from operations.
Advisors' Opinion:- [By James E. Brumley]
How does the old saying go? Beggars can't be choosers? Two weeks ago, yours truly penned some bullish comments regarding OncoSec Medical Inc. (OTCMKTS:ONCS). The long and short of it was, if ONCS could clear a technical ceiling around $0.36, then life would get much easier for the bulls.
- [By Bio-Wire]
Another company that has benefitted from Inovio�� newfound attention is OncoSec Medical (OTC: ONCS) ��a newer ��ffshoot�� company that uses a similar but distinctly different electroporation device known as the OncoSec Medical System (OMS) that is based on Inovio�� technology. The specific amplitude and frequency of the OMS electroporation is calibrated such that plasmid delivery into solid tumor masses is fully optimized, while CELLECTRA electroporation is less specialized and focus more on the vaccination of skin cells. The cross-license agreement made between Inovio and Oncosec also covers the two devices for their distinctly different applications.
- [By John Udovich]
Small cap biotech stocks AVEO Pharmaceuticals, Inc (NASDAQ: AVEO), OncoSec Medical Inc (OTCMKTS: ONCS) and MetaStat Inc (OTCBB: MTST) are focused on or are developing treatments or diagnostic technologies for metastatic cancers. In case you aren�� familiar with the term metastasis or metastatic, it�� the�spread of cancer from its primary site to other places in the body as cancer cells break away from a primary tumor, penetrate into lymphatic and blood vessels, circulate through the bloodstream and then grow in a new focus (metastasize) in normal tissues elsewhere in the body. In other words, it�� a dangerous form of cancer, but there are some small cap biotech stocks targeting it for diagnostics or treatment:
- [By James E. Brumley]
If you're looking for the next big biotech breakout stock, then OncoSec Medical Inc. (OTCMKTS:ONCS) deserves a place on your watchlist. This volatile cancer play has been down more than up 2011, but if you look closely at a long-term chart of ONCS, you may find it's already wiggled its way into a new uptrend. And, it may be only a matter of time before the bullish fireworks start to go off.
10 Best Life Sciences Stocks To Own For 2014: Sonoco Products Company(SON)
Sonoco Products Company provides industrial and consumer packaging products, and packaging services worldwide. It offers composite paperboard cans; paperboard packages; fiber cartridges; layered bottles and jars; laminated tubs, cups, and spools; consumer and institutional trays; and aluminum, steel, and peelable membrane easy-open closures, as well as flexible packaging, product design, tool design, fabrication, and manufacturing services. The company also produces paperboard tubes, cores, roll packaging, molded plugs, pallets, pallet components, concrete forms, rotary die boards, recycled paperboard, chipboard, tube board, lightweight corestock, boxboard, linerboard, corrugating medium, specialty grades, and recovered paper products; and steel, nailed wooden, plywood, recycled, and polyfiber reels, as well as recycles old corrugated container, paper, plastic, metal, and glass materials. In addition, it manufactures custom-printed glass covers and coasters; offers custom packing, fulfillment, and primary package filling services, as well as operates scalable service centers; contract packaging, co-packing, and fulfillment services; and temporary, semipermanent, and permanent point-of-purchase displays. Further, the company provides fabricated foam, corrugated paperboard, molded EPS and EPP, antistatic fabricated foam solutions, nesting and stacking trays, molded foam dunnage, totes and tote inserts, energy-absorbing and flotation components, and insulation components, as well as contract package testing service. Additionally, it offers insulated shippers, durable transport chests, gel packs, phase change materials, lab/pharma/diagnostic specimen transport, refrigerant materials, edge and corner protection, and temperature assurance solutions; high-visibility packaging and printed products; and blister packaging machines. The company, formerly known as Southern Novelty Company, was founded in 1899 and is based in Hartsville, South Carolina. Advisors' Opinion:
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Sonoco Products (NYSE: SON ) , whose recent revenue and earnings are plotted below.
No comments:
Post a Comment